These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In search of a compromised solution to the problem arising from patenting biomedical research tools. Derzko NM Santa Clara Comput High Technol Law J; 2004; 20(2):347-410. PubMed ID: 16493840 [No Abstract] [Full Text] [Related]
5. Gene patenting and medical research: a view from a pharmaceutical company. Stott M; Valentine J Nat Rev Drug Discov; 2004 Apr; 3(4):364-8. PubMed ID: 15060532 [No Abstract] [Full Text] [Related]
6. Companies balk at California's patent rules for stem cell research. Keim B Nat Med; 2007 Jan; 13(1):6. PubMed ID: 17206112 [No Abstract] [Full Text] [Related]
7. Protection for manufacturing, not research. Nat Rev Drug Discov; 2003 Oct; 2(10):766. PubMed ID: 14579809 [No Abstract] [Full Text] [Related]
8. Much ado about gene patents: the role of foreseeability. Gulliford MJ Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032 [No Abstract] [Full Text] [Related]
9. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp]. Westerlund L Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544 [No Abstract] [Full Text] [Related]
10. A modest proposal: toward improved access to biotechnology research tools by implementing a broad experimental use exception. Hoffman DC Cornell Law Rev; 2004 May; 89(4):993-1043. PubMed ID: 15174465 [No Abstract] [Full Text] [Related]
11. A guide to drug discovery. Protecting your inventions: the patent system. Webber PM Nat Rev Drug Discov; 2003 Oct; 2(10):823-30. PubMed ID: 14526385 [TBL] [Abstract][Full Text] [Related]
12. Should the patent system for new medicines be abolished? DiMasi JA; Grabowski HG Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100 [No Abstract] [Full Text] [Related]
14. Enforcing pharmaceutical and biotech patent rights in China. Zhang YP; Deng MM Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760 [No Abstract] [Full Text] [Related]
15. The MTA-rip it up and start again? Ku K; Henderson J Nat Biotechnol; 2007 Jul; 25(7):721-4. PubMed ID: 17621290 [No Abstract] [Full Text] [Related]
16. Dangerous copyright proposals hit medical community hard. Geist M CMAJ; 2005 Apr; 172(8):989-90. PubMed ID: 15824398 [No Abstract] [Full Text] [Related]
17. Access to tangible research materials in biomedical research: conditions of access and their effect on research. Monotti AL J Law Med; 2006 Aug; 14(1):86-101. PubMed ID: 16937783 [TBL] [Abstract][Full Text] [Related]
18. Biotechnology: a challenge for Hippocrates. Huynen S Auckl Univ Law Rev; 1991; 6(4):534-51. PubMed ID: 16127862 [No Abstract] [Full Text] [Related]
19. Research interactions between industry and academia: a corporate perspective. Citron P Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116 [No Abstract] [Full Text] [Related]
20. Science and law. Intellectual property and human embryonic stem cell research. Loring JF; Campbell C Science; 2006 Mar; 311(5768):1716-7. PubMed ID: 16556826 [No Abstract] [Full Text] [Related] [Next] [New Search]